Playback speed
10 seconds
This video is featured in the 2024 ESMO Annual Meeting Insights Hub
ESMO 2024 Insights: Treatment Rechallenge After Grade 1 Trastuzumab-Deruxtecan Related ILD - A Real-World Experience
By
2024 ESMO Annual Meeting Insights Hub
FEATURING
Kelsey Natsuhara
By
2024 ESMO Annual Meeting Insights Hub
FEATURING
Kelsey Natsuhara
731 views
October 14, 2024
Comments 0
Login to view comments.
Click here to Login